These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 38360550)

  • 21. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.
    Qin Q; Shi A; Zhang R; Wen Q; Niu T; Chen J; Qiu Q; Wan Y; Sun X; Xing L
    Thorac Cancer; 2020 Apr; 11(4):964-972. PubMed ID: 32061061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Application of a Radiomics Model for Preding Lymph Node Metastasis in Non-small Cell Lung Cancer].
    Zhu J; Xu WG; Xiao H; Zhou Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 May; 50(3):373-378. PubMed ID: 31631606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-Region Computed Tomography Radiomics-Based Machine Learning Predicts Subcarinal Lymph Node Metastasis in Patients with Non-small Cell Lung Cancer.
    Yan HJ; Zhao JS; Zuo HD; Zhang JJ; Deng ZQ; Yang C; Luo X; Wan JX; Zheng XY; Chen WY; Li SP; Tian D
    Ann Surg Oncol; 2024 Aug; 31(8):5011-5020. PubMed ID: 38520581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of CT radiomics features to predict visceral pleural invasion in ≤3 cm peripheral type early non-small cell lung cancer.
    Wei SH; Zhang JM; Shi B; Gao F; Zhang ZX; Qian LT
    J Xray Sci Technol; 2022; 30(6):1115-1126. PubMed ID: 35938237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
    Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
    Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of programmed death-1 expression status in non-small cell lung cancer based on intratumoural and peritumoral computed tomography (CT) radiomics nomogram.
    Tian Q; Jia JY; Qin C; Zhou H; Zhou SY; Qin YH; Wu YY; Shi J; Duan SF; Feng F
    Clin Radiol; 2024 Sep; 79(9):e1089-e1100. PubMed ID: 38876960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Validation of a CT-Based Signature for the Prediction of Distant Metastasis Before Treatment of Non-Small Cell Lung Cancer.
    Tao J; Lv R; Liang C; Fang J; Liu D; Lan X; Huang H; Zhang J
    Acad Radiol; 2022 Feb; 29 Suppl 2():S62-S72. PubMed ID: 33402298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting N2 lymph node metastasis in presurgical stage I-II non-small cell lung cancer using multiview radiomics and deep learning method.
    Zhang H; Liao M; Guo Q; Chen J; Wang S; Liu S; Xiao F
    Med Phys; 2023 Apr; 50(4):2049-2060. PubMed ID: 36563341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of a Comprehensive Model Based on CT Radiomics and Clinical Features for Postoperative Recurrence Risk Prediction in Non-small Cell Lung Cancer.
    Wang P; Luo Z; Luo C; Wang T
    Acad Radiol; 2024 Jun; 31(6):2579-2590. PubMed ID: 38172022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating Imaging, Histologic, and Genetic Features to Predict Tumor Mutation Burden of Non-Small-Cell Lung Cancer.
    Zhang N; Wu J; Yu J; Zhu H; Yang M; Li R
    Clin Lung Cancer; 2020 May; 21(3):e151-e163. PubMed ID: 31734072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Radiomics Signature in Preoperative Predicting Degree of Tumor Differentiation in Patients with Non-small Cell Lung Cancer.
    Chen X; Fang M; Dong D; Wei X; Liu L; Xu X; Jiang X; Tian J; Liu Z
    Acad Radiol; 2018 Dec; 25(12):1548-1555. PubMed ID: 29572049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of CT Radiomics and Clinical Features in Predicting Bone Metastases in Patients with NSCLC.
    Chen L; Yu L; Li X; Tian Z; Lin X
    Contrast Media Mol Imaging; 2022; 2022():7642511. PubMed ID: 36051936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiomics feature analysis and model research for predicting histopathological subtypes of non-small cell lung cancer on CT images: A multi-dataset study.
    Song F; Song X; Feng Y; Fan G; Sun Y; Zhang P; Li J; Liu F; Zhang G
    Med Phys; 2023 Jul; 50(7):4351-4365. PubMed ID: 36682051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell Lung Cancer: A Retrospective Multicohort Study.
    Tong H; Sun J; Fang J; Zhang M; Liu H; Xia R; Zhou W; Liu K; Chen X
    Front Immunol; 2022; 13():859323. PubMed ID: 35572597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition.
    Li Y; Wang P; Xu J; Shi X; Yin T; Teng F
    Oncoimmunology; 2024; 13(1):2312628. PubMed ID: 38343749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing brain metastasis prediction in non-small cell lung cancer: a deep learning-based segmentation and CT radiomics-based ensemble learning model.
    Gong J; Wang T; Wang Z; Chu X; Hu T; Li M; Peng W; Feng F; Tong T; Gu Y
    Cancer Imaging; 2024 Jan; 24(1):1. PubMed ID: 38167564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and Validation of a Radiomics Nomogram Using Computed Tomography for Differentiating Immune Checkpoint Inhibitor-Related Pneumonitis From Radiation Pneumonitis for Patients With Non-Small Cell Lung Cancer.
    Qiu Q; Xing L; Wang Y; Feng A; Wen Q
    Front Immunol; 2022; 13():870842. PubMed ID: 35558076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiparameter spectral CT-based radiomics in predicting the expression of programmed death ligand 1 in non-small-cell lung cancer.
    Zheng XX; Ma YQ; Cui YQ; Dong SS; Chang FX; Zhu DL; Huang G
    Clin Radiol; 2024 Apr; 79(4):e511-e523. PubMed ID: 38307814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.